A complete application in a minute
Tailored resume and cover letter, ready to send.
Regeneron Pharmaceuticals, Inc is seeking a Digital Health Technology Associate Manager to drive the implementation of digital tools (eCOA, eConsent, wearables) in clinical studies from design through close-out. You will manage timelines, specifications, and UAT, ensuring compliance with Regeneron SOPs and ICH/GCP.
You will lead study delivery, vendor oversight, and cross-functional collaboration, with travel up to 25% to support multiple trials across sites and CROs.
Build our future together: The Digital Health Technology Associate Manager (DHT AM) is responsible for implementing digital tools and technologies - electronic COA (eCOA), eConsent, wearables, sensors, spirometry, ECG, and similar - in individual clinical research studies, from study design through close-out, in collaboration with the study team. A typical day includes managing project timelines, translation, specifications, and UAT activities (either direct execution or oversight), ensuring data collection complies with Regeneron SOPs and ICH/GCP. This role applies to both internally sourced studies and studies outsourced to CROs, and includes responsibility for managing vendor activities and training/educating stakeholders.
Proactive and self-disciplined; able to meet deadlines, manage time effectively, and prioritize
Education: Bachelor’s degree required (equivalent experience in lieu of degree may be acceptable, though number of years was not specified in the source document)
Experience: Minimum of 6+ years of relevant industry experience
Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship. Where necessary, we disclose salary ranges for roles in all countries in which we operate. The final offer will be determined within the relevant range based on the country of employment, specific role level, and your skills and experience. In some countries, collective bargaining agreements (CBAs) may apply and influence certain elements of pay or benefits. We are committed to building a workplace with an inclusive culture.
Salary Range (annually) $98,100.00 - $160,100.00
Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role: annual bonuses or other incentive plans, equity awards, pension or retirement benefits, 401(k) company match, health and wellness programs, fitness centers, insurance benefits (e.g. medical, dental, vision, life and disability), paid time off, and family support benefits.
Please be advised that at Regeneron, we believe we do our best work when we are together. For that reason, many roles are required to be performed on-site. Please speak with your recruiter and hiring manager for more information about on-site expectations for your role and location.
As part of the recruitment process, certain background checks may be conducted in accordance with the laws of the country where the position is based. The purpose of such checks is to verify certain information prior to the commencement of employment such as identity, right to work and educational qualifications. For jobs in Canada: this posting is for an existing position.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, infectious diseases and rare diseases. Regeneron is also proud of award winning culture of innovation, being recognized as a Great Place to Work in 2021, Fast Company’s Best Workplace for Innovators in 2020, and Forbes JUST companies in 2020, among others.